Search

everythinglearnresearchcommunity

for

Search:↓

Anti-TNF-α therapy may increase the risk of developing alopecia areata, especially in those with a history of autoimmune disease.

The silk fibroin-based hydrogel shows promise for treating melanoma and healing infected wounds by killing tumor cells and bacteria, and supporting skin recovery.

Cylindromas likely originate from hair follicle stem cells, not sweat glands.

Vitamin D and its receptor may help prevent skin cancer.

Blocking certain proteins can reduce skin inflammation caused by cancer treatment.

Stem cells in the skin help with healing and can also lead to cancer.

Tumor suppressors help control inflammation in cancer and restoring their function could lead to new treatments.

CYLD mutations cause a variety of skin tumors with symptoms starting around age 16, and treatments are currently limited.

Antizyme slows skin tumor growth by reducing cell growth in mice.

High levels of TNF-α may contribute to obesity and insulin resistance in PCOS, but not due to the C850T genetic variation.

Some drugs used to treat inflammation may cause hair loss.

The extracellular matrix affects where tumors can start in the body.

TNFα, IFNγ, and Substance P significantly affect prolactin levels in human skin, suggesting new treatments for skin and hair conditions.

Fluorescent proteins help visualize and understand tumor blood vessel growth.

TMPRSS2 helps viruses enter cells and protects the prostate from inflammation-related cancer.

Some skin tumors may start from hair follicle stem cells.

Folliculotropic mycosis fungoides can affect the central nervous system in advanced stages.

Topical eye β-blockers might cause hair loss, which usually gets better after stopping the medication.

Active oxygen species might be involved in skin tumor growth, but their exact role is unclear.

Lower TNF-α levels in PRP may predict better treatment outcomes for bladder conditions.

Lgr5+ stem cells do not cause skin tumors.

The type of tumor suppressor affects the form of skin cancer from hair follicle stem cells.

TNF-inhibitor induced alopecia can be treated effectively with different therapies.

IL-15 and TNF-α levels are higher in alopecia areata patients, especially in alopecia totalis.

The type of tumor suppressor gene lost affects the behavior of skin cancer.

Oral pulse steroids reduce TNF-α levels, improving alopecia areata.

DNA virus-induced tumors have consistent isozyme profiles, unlike other tumor types.

Tumor proteins can both promote and suppress cancer, depending on the situation.

Stopping TNFα inhibitors can help children regrow hair lost due to the medication.

Recognizing rare tumor combinations is crucial for accurate diagnosis and treatment.